Literature DB >> 6724667

Free calcium concentration in platelets closely relates to blood pressure in normal and essentially hypertensive subjects.

P Erne, E Bürgisser, P Bolli, B H Ji, F R Bühler.   

Abstract

Calcium has been implicated in smooth muscle contraction, arterial resistance, and the pathophysiology of essential hypertension. Using the intracellularly trapped fluorescent dye quin2 , the free calcium concentration in platelets was found to be elevated in patients with borderline (n = 8, p less than 0.01) and established essential hypertension (n = 23, p less than 0.001) when compared with normotensive subjects (n = 30). There was a close correlation between intracellular free calcium and systolic blood pressure (n = 61, r = 0.882, p less than 0.001) as well as diastolic blood pressure (n = 61, r = 0.950, p less than 0.001). The slopes of the regression lines did not differ between the groups.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6724667     DOI: 10.1161/01.hyp.6.2_pt_2.i166

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  5 in total

Review 1.  The role of calcium supplementation in the treatment of hypertension. Current evidence.

Authors:  D E Grobbee; H J Waal-Manning
Journal:  Drugs       Date:  1990-01       Impact factor: 9.546

2.  Ion channel effects of pinacidil in vascular muscle.

Authors:  K Hermsmeyer
Journal:  Drugs       Date:  1988       Impact factor: 9.546

3.  Intracellular calcium and blood pressure: comparison between primary hyperparathyroidism and essential hypertension.

Authors:  C Fardella; J A Rodriguez-Portales
Journal:  J Endocrinol Invest       Date:  1995-12       Impact factor: 4.256

4.  Ethanol and platelet intracellular free calcium concentrations.

Authors:  K R Lees; S M Barr; L Butters; P C Rubin
Journal:  Br J Clin Pharmacol       Date:  1987-07       Impact factor: 4.335

5.  The 5-hydroxytryptamine receptor of blood platelets.

Authors:  A Pletscher; H Affolter
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.